2TX.F - Asensus Surgical, Inc.
| Previous Close | 0.4320 |
| Open | 0.4420 |
| Bid | 0.4340 x N/A |
| Ask | 0.5200 x N/A |
| Day's Range | 0.4420 - 0.4420 |
| 52 Week Range | 0.2580 - 1.0300 |
| Volume | |
| Avg. Volume | 804 |
| Market Cap | 114.881M |
| Beta (5Y Monthly) | 1.78 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2800 |
| Earnings Date | Aug 07, 2023 - Aug 11, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.00 |
GlobeNewswireAsensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2023
RESEARCH TRIANGLE PARK, N.C., May 11, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the first quarter 2023. Recent Highlights 20% year-over-year growth in surgical procedures, with over 900 procedures performed globally during the quarterSurpassed 10,000 procedures on Sen
- GlobeNewswire
Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2023
RESEARCH TRIANGLE PARK, N.C., April 27, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™ (PGS), announced today that it plans to release 2023 first quarter financial and operating results after the market closes on Thursday, May 11, 2023. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the
GlobeNewswireAsensus Surgical Announces Fukuoka Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
System to be Utilized by the Second Largest Private Hospital System in Japan The Senhance Surgical System The Senhance Surgical System is the only commercially available robotic surgery system with haptic feedback, a differentiating feature for surgeons. RESEARCH TRIANGLE PARK, N.C., April 25, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc., (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Gui
- GlobeNewswire
Asensus Surgical to Participate in the H.C. Wainwright In-Person BioConnect Investor Conference
RESEARCH TRIANGLE PARK, N.C., April 19, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H.C. Wainwright In-Person Bio-Connect Investor Conference. The Company’s fireside chat will take place on Tuesday, May 2, 2023 at 11:30 am Eastern Time. The conference webcast will be available online on the inv
- GlobeNewswire
Asensus Surgical Receives FDA 510(k) Clearance For Pediatric Indication for Senhance Surgical System
Senhance Offers the First and Only Digital Laparoscopic Surgery Solution for Pediatric PatientsRESEARCH TRIANGLE PARK, N.C., March 20, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™ (PGS), today announced that it has received 510(k) clearance from the FDA for an expanded indication to treat pediatric patients with the Senhance®
- GlobeNewswire
Asensus Surgical to Participate in the Oppenheimer 33rd Annual Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., March 06, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 33rd Annual Healthcare Conference. The Company’s virtual presentation will take place on Monday, March 13 at 2:00 pm Eastern Time. The conference webcast will be available online on the investor rela
- GlobeNewswire
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2022
RESEARCH TRIANGLE PARK, N.C., March 02, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™(PGS), today announced its operating and financial results for the fourth quarter and full year 2022. As the Company hosted an Investor Day on Tuesday, February 21, 2023 during which an in-depth review of the business was provided, the Company
- GlobeNewswire
Asensus Surgical, Inc. to Release Fourth Quarter and Full Year 2022 Financial and Operating Results on March 2, 2023
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release fourth quarter and full year 2022 financial and operating results after the market closes on Thursday, March 2, 2023. As the Company hosted an Investor Day on Tuesday, February 21, 2023 during which an
GlobeNewswireAsensus Surgical Provides Corporate Update
The LUNA Surgical System The LUNA Surgical System is Asensus’ next generation digital surgery platform that is poised to revolutionize the way surgery is performed. RESEARCH TRIANGLE PARK, N.C., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, is providing this corporate update in conjunction with its previously announce
- GlobeNewswire
Asensus and KARL STORZ to Market the Intelligent Surgical Unit and Co-Develop New Vision and Instrument Platforms
The Companies intend to collaborate on developing next-generation instrumentation and KARL STORZ intends to sell Asensus’ Intelligent Surgical Unit (ISU) as a standalone deviceRESEARCH TRIANGLE PARK, N.C., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company has entered into a Memorandum of U
- GlobeNewswire
Asensus Surgical Announces Machine Learning and Cloud Infrastructure Collaboration with Google Cloud to Advance Performance-Guided Surgery
RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, today announced a multi-year collaboration with Google Cloud to integrate Google Cloud’s secure cloud data architecture and machine learning (ML) technologies to further expand the capabilities of the Asensus Surgical’s Performance-Guided Surgery™ (PGS) framework enabled through the Intelligent
- GlobeNewswire
Asensus Surgical to Ring New York Stock Exchange Opening Bell on February 21, 2023
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient, today announced that President and CEO Anthony Fernando will be joined by other leaders of the Company to ring the opening bell of the New York Stock Exchange on February 21, 2023. On the same day, the Company is hosting an Investor Day. "We are honored to ring the New York Stock Exchange openi
- GlobeNewswire
Asensus Surgical to Host Investor Day on February 21, 2023
RESEARCH TRIANGLE PARK, N.C., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Company will host an Investor Day on Tuesday, February 21, 2023 in New York City. 2023 Investor Day Overview Date: Tuesday, February 21, 2023 Time: 11:30 AM EST Location: InterContinental New York Barclay Hotel A live
GlobeNewswireAsensus Surgical Receives CE Mark for Expanded Machine Vision Capabilities
Expanded Intelligent Surgical Unit™ (ISU™) capabilities include 3D measurement, digital tagging, image enhancement, and enhanced camera control, for our European customers The Senhance Surgical System The Senhance Surgical System is powered by the Intelligent Surgical Unit, enabling real-time surgical image analytics and machine vision-driven control of the camera. RESEARCH TRIANGLE PARK, N.C., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device compa
- GlobeNewswire
Asensus Surgical Provides Preliminary 2022 Year-End Corporate Update
RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today provided a preliminary 2022 year-end corporate update. Fourth Quarter Highlights Over 690 procedures were performed globally during the quarter, representing growth of over 23% compared to the fourth quarter 2021Five Senhance® Surgical P
- GlobeNewswire
Asensus Surgical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the management team will participate and present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 PM PST. Event: 41st Annual J.P. Morgan Healthcare Conference Date: Thursday, Janu
- GlobeNewswire
Asensus Announces Kitakyushu General Hospital in Japan to Initiate Second Senhance System
First hospital to install a second Senhance Surgical SystemRESEARCH TRIANGLE PARK, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Kitakyushu General Hospital (“Kitakyushu”), a hospital in the Kyushu area of Japan, entered into an agreement to lease and utilize a second Senhance® Surgical Syst
- GlobeNewswire
Asensus Announces Senhance Program Initiation at Kashiwa Kosei General Hospital of Japan
Continued expansion of the Senhance Program in the regionRESEARCH TRIANGLE PARK, N.C., Dec. 29, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Kashiwa Kosei General Hospital in Kashiwa, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System. “We are pleased to be partnering wit
GlobeNewswireAsensus Announces Senhance System Placement at GPR Klinikum Rüsselsheim of Germany
10th hospital in Germany to initiate a Senhance System The Senhance Surgical System The Senhance Surgical System advances clinical intelligence by providing surgeons with augmented intelligence and digital tools to perform consistently superior surgery. RESEARCH TRIANGLE PARK, N.C., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided
- GlobeNewswire
Asensus Announces Additional Senhance Surgical System Sale
Oncology focused hospital to initiate Senhance System programRESEARCH TRIANGLE PARK, N.C., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that a Senhance® Surgical System has been sold to the Company’s distribution partner in Germany focused on Eastern Europe and the Commonwealth of Independent States (
- GlobeNewswire
Asensus Surgical to Participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference in Miami, Florida. The Company’s panel presentation, Launching on Society: Early Commercial MedTech Names with New Technologies in Large Patient Populations, will take place on Thursday, December 8,
- GlobeNewswire
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2022
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2022. Recent Highlights Over 1,900 procedures were performed globally during the nine months ended September 30, 2022, representing growth of 27% over the prior yearFive
GlobeNewswireAsensus Surgical Announces Ludwig Maximilians University in Germany to Initiate Senhance Pediatric Surgery Program
Senhance Surgical System Senhance Surgical System First Hospital to Initiate a Senhance System Dedicated to Pediatric Procedures9th Hospital in Germany to Utilize Senhance RESEARCH TRIANGLE PARK, N.C., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that the Dr. von Hauner Children’s Hospital at the Ludw
- GlobeNewswire
Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 10, 2022
RESEARCH TRIANGLE PARK, N.C., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2022 third quarter financial and operating results after the market closes on Thursday, November 10, 2022. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same
NewsfileAsensus Surgical, Inc. To Present at The LD Micro Main Event XV
Presentation on Tuesday, October 25 at 8:30 am PT Research Triangle Park, North Carolina--(Newsfile Corp. - October 18, 2022) - Asensus Surgical, Inc. (NYSE American: ASXC), Asensus Surgical, a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced today that it will be presenting at the 15th annual Main Event on Tuesday, October 25th at 8:30 AM PT at the Luxe ...